Exelixis finalizes separation with former CMO Vicki Goodman, consulting through Dec 2023

EXELIXIS, INC.

Dr. Goodman concluded service as EVP Product Development & CMO effective August 23, 2023.
Separation agreement provides severance payments and benefits under company's Change in Control and Severance Benefit Plan, payable in lump sum.
Consulting agreement for up to 4 months (Sept 1 to Dec 31, 2023) with monthly fee of $20,000.
Consulting may be terminated by either party with 5 business days' notice.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Vicki L. Goodman

Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer

EXEL · EXELIXIS, INC.

Effective: 2023-08-23
Filed: September 19, 2023, 7:59 PM ET

Vicki L. Goodman, M.D., concluded her service as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer of the Company, effective as of August 23, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Vicki L. Goodman departed as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer at EXELIXIS, INC..

Action: concluded
Role: Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer

Exact text from the filing

Vicki L. Goodman, M.D., concluded her service as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer of the Company, effective as of August 23, 2023.

View on SEC.gov

EXELIXIS, INC. filing history →

Source: SEC EDGAR

accession 0000939767-23-000109

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.